Modulating the Treg/Th2 response by decreasing proinflammatory cytokines such as TNFα, IL-6, IL-1β, IL-18, IL-22, IL-9 and increasing anti-inflammatory cytokines IL-10 and IL-4 in mice colitis model. The gene discussed is IL9; the disease is colitis.